Stop Stalling Access to Affordable Medications

HB 2883 Stop Stalling Access to Affordable Medications

US Congress 117th Congress

Stop Stalling Access to Affordable Medications
HB-2883

About HB-2883

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.

  

Bill Texts

Introduced 06/17/2021

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Spread the Word!

Gettr Embed Code

Sponsors (9)

Rep. David Cicilline


Co-Sponsor

Rep. Hakeem Jeffries


Primary Sponsor

Rep. Jerrold Nadler


Co-Sponsor

Rep. Sheila Jackson-Lee


Co-Sponsor

Rep. Val Demings


Co-Sponsor

Rep. Carolyn Maloney


Co-Sponsor

Sen. Ted Budd


Co-Sponsor

Rep. Ken Buck


Co-Sponsor

Rep. Burgess Owens


Co-Sponsor

Track This Bill

Get notified when this bill is updated

Sponsors by party

     

Bill Sponsors

History

Committee Consideration And Mark-up Session Held.

09/29/2021

Ordered To Be Reported In The Nature Of A Substitute By The Yeas And Nays: 31 - 9.

09/29/2021

Introduced In House

04/28/2021

Referred To The House Committee On The Judiciary.

04/28/2021

Subject(s)

Health Administrative Law And Regulatory Procedures Business Ethics Civil Actions And Liability Competition And Antitrust Drug Safety, Medical Device, And Laboratory Regulation Federal Trade Commission (ftc) Licensing And Registrations Public Participation And Lobbying Administrative Remedies Department Of Health And Human Services Food And Drug Administration (fda) Prescription Drugs